Physician profile
Joseph Pedone
NPI 1093816696
$2,011.21
in general payments reported to CMS, 2019-2025
19 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.89 · 2020: $245 · 2021: $243 · 2022: $719 · 2023: $121 · 2024: $320 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $457.25 | 2020-2025 | Aveir, Jot Dx |
| Shockwave Medical, INC | $187.50 | 2021 | |
| Edwards Lifesciences Corporation | $186.62 | 2022 | |
| Boston Scientific Corporation | $157.45 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $144.73 | 2022-2025 | Camzyos |
| Pfizer INC. | $132.01 | 2019-2025 | |
| Biotronik INC. | $131.31 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $123.73 | 2020 | |
| Novo Nordisk INC | $92.63 | 2024-2025 | Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $76.45 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $66.14 | 2023-2024 | Verquvo |
| Philips North America LLC | $53.10 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Irhythm Technologies, INC. | $49.75 | 2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $39.55 | 2021 | |
| Kestra Medical Technology Services, INC. | $29.68 | 2023 | Assure Wcd |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $26.29 | 2019 | |
| Abiomed | $21.08 | 2023 | Impella |
| Scpharmaceuticals INC. | $20.02 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pedone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.